You just read:

Regulatory Approval - FDA Approves Shire’s Xiidra™ (lifitegrast ophthalmic solution) 5% – The Only Treatment Indicated for the Signs and Symptoms of Dry Eye Disease

News provided by

Shire plc

Jul 11, 2016, 07:08 ET